During IAS 2010 in Vienna, UNITAID’s Ellen ‘t Hoen gave a plenary presentation on the organization’s new Medicines Patent Pool Initiative, a project that began to take shape in 2008. Hoen leads the program, which aims to lower the cost of HIV/AIDS, malaria and tuberculosis drugs by working with pharmaceutical companies to allow generic production […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]